Joint HMA/EMA workshop on artificial intelligence in medicines regulation

EventHumanInnovation

Date: Monday, 19 April 2021
Location: Online
European Medicines Agency, Amsterdam, the Netherlands

Event summary

Artificial intelligence (AI) and novel digital technologies hold the promise of increasing efficiency and capacity in healthcare and of providing deeper insights from big data. The HMA-EMA Joint Big Data Task Force recommended to strengthen the network ability in AI, which is reflected in the Big Data Steering Group work plan.

The objective of this workshop is to:

Inform on state-of-the art use of AI in medicines with keynote presentations;
Hear the views of stakeholders and experts on the AI actions in the Big Data Taskforce and identify any gaps.

For more information, see Big data.

Documents

Report of the joint HMA/EMA workshop on artificial intelligence in medicines regulation

Reference Number: EMA/292319/2021

English (EN) (332.63 KB - PDF)

First published: 28/05/2021

Agenda - Joint HMA/EMA workshop on artificial intelligence in medicines regulation

DraftReference Number: EMA/176509/2021

English (EN) (155.74 KB - PDF)

First published: 24/03/2021Last updated: 19/04/2021

Presentation - International Coalition of Medicines Regulatory Authority (ICMRA) - Artificial intelligence recommendation (Agnes Saint-Raymond)

English (EN) (608.11 KB - PDF)

First published: 05/05/2021

Presentation - Artificial Intelligence to improve the lives of patients (Andre Dekker)

English (EN) (1.79 MB - PDF)

First published: 05/05/2021

Presentation - Translating a trillion points of data into real world evidence and enabled intelligence for medicine (Atul Butte)

English (EN) (4.46 MB - PDF)

First published: 05/05/2021

Presentation - Company experience of using artificial intelligence to aid drug development (Boris Braylyan)

English (EN) (592.34 KB - PDF)

First published: 05/05/2021

Presentation - Big Data Taskforce recommendations and regulatory science strategy on artificial intelligence (Gianmario Candore)

English (EN) (419.28 KB - PDF)

First published: 05/05/2021

Presentation - EMA's network strategy to 2025 - Strategy for digital transformation (Jesper Kjær)

English (EN) (427.5 KB - PDF)

First published: 05/05/2021

Presentation - Artificial intelligence and digitalisation at EMA (Joaquim Jornet, Florence Butlen)

English (EN) (707 KB - PDF)

First published: 05/05/2021

Presentation - Big data training survey (Jörg Zinserling)

English (EN) (180.24 KB - PDF)

First published: 05/05/2021

Presentention - Artificial intelligence in therapeutic development - A policy perspective (Khair El Zarrad)

English (EN) (2.7 MB - PDF)

First published: 05/05/2021

Presentation - Artificial intelligence, digital twins and the promise of personalised medicine (Liesbet Geris)

English (EN) (2.69 MB - PDF)

First published: 05/05/2021

Presentation - Novel methods in pharmacovigilance - Use cases in VigiBase (Lucie Gattepaille)

English (EN) (2.38 MB - PDF)

First published: 05/05/2021

Presentation - Putting machine learning into real-world practice patient-level prediction development and validation in observational data (Peter Rijnbeek)

English (EN) (2.05 MB - PDF)

First published: 05/05/2021

Presentation - Artificial intelligence in medical devices and digital healthcare applications – the BfArM perspective (Wolfgang Lauer)

English (EN) (2.94 MB - PDF)

First published: 05/05/2021

Video recordings

Day 1

Day 2